文献速递银屑病与炎症性皮肤病

中国银屑病队列TNF-α抑制剂治疗期间外周血转录组动态变化

Time-course blood transcriptome dynamics of TNF-α inhibitor therapy in a Chinese cohort with psoriasis.
PubMed 文献 · J Invest Dermatol · 2026-09-09

该研究对86例接受TNF-α抑制剂治疗的斑块状银屑病患者在3个时间点进行外周血转录组分析,鉴定出3351个时间进程药物应答基因,富集于免疫信号和细胞活化通路。应答者与非应答者在OLIG1、LRRK1、KSR1、TNFAIP3和MPP7表达上存在差异,且「红色」共表达模块与治疗结局负相关,TNFSF10高表达与不良结局相关。应答者第2周红色模块共表达模式已显著改变。

要点

  • TNF-α抑制剂治疗银屑病可动态调控外周血免疫信号和细胞活化相关基因。
  • OLIG1、LRRK1、KSR1高表达及TNFAIP3、MPP7低表达与治疗应答相关。
  • TNFSF10高表达与不良结局相关,第2周红色模块变化可区分应答者。

核心结论

  • 研究刻画了斑块状银屑病患者接受TNF-α抑制剂治疗期间外周血转录组的时间进程变化。
  • 应答者与非应答者存在基线或治疗早期的基因表达差异,且第2周红色模块共表达模式可区分应答状态。

研究设计与样本

  • 研究纳入86例接受TNF-α抑制剂治疗的斑块状银屑病患者,在3个时间点采集外周血进行转录组分析。
  • 研究鉴定了时间进程药物应答基因,并与银屑病皮损和血液表达及炎症性肠病共享基因进行比较。

主要发现

  • 鉴定出3351个时间进程药物应答基因,富集于免疫信号和细胞活化通路,并在银屑病皮损和血液中表达。
  • 其中259个基因在至少一对采样时间点间差异表达,962个基因与炎症性肠病共享。
  • 应答者OLIG1、LRRK1、KSR1表达高于非应答者,TNFAIP3和MPP7表达低于非应答者。
  • 「红色」共表达模块与治疗结局负相关,富集于炎症和TNF相关通路,其顶部枢纽基因TNFSF10高表达与不良结局相关。
  • 第2周时,应答者红色模块共表达模式显著改变,非应答者未改变。

临床怎么用

  • 外周血转录组动态变化可能有助于早期识别TNF-α抑制剂治疗应答者与非应答者。
  • OLIG1、LRRK1、KSR1、TNFAIP3、MPP7及TNFSF10等基因表达水平可作为潜在生物标志物进一步验证。

局限性

  • 研究仅纳入中国斑块状银屑病队列,结果外推需谨慎。
  • 样本量有限,生物标志物的临床效用需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TNF-α inhibitors are effective biologics for immune-mediated inflammatory diseases, including plaque psoriasis and inflammatory bowel disease. However, time-course peripheral blood transcriptomic changes during treatment remain poorly characterized. To characterize transcriptomic changes associated with TNF-α inhibitor treatment, we profiled blood transcriptomics at 3 time points in 86 patients with plaque psoriasis receiving a TNF-α inhibitor. We identified 3351 time-course drug-response genes that were enriched in immune signaling and cell activation pathways and expressed in psoriatic skin lesions and blood. Among them, 259 genes were differentially expressed between at least 1 pair of the 3 sampling time points, and 962 were shared between psoriasis and inflammatory bowel disease. TNF-α inhibitor responders showed higher expression of OLIG1, LRRK1, and KSR1 and lower expression of TNFAIP3 and MPP7 than nonresponders. We identified a "red" gene coexpression module that was negatively correlated with treatment outcome and enriched in inflammation and TNF-related pathways. High expression of TNFSF10 (the top hub gene of the "red" module) was associated with a poor outcome. By week 2, the red module's coexpression pattern had changed significantly in responders but not in nonresponders. This study characterizes the time-course peripheral blood transcriptional programs of TNF-α inhibitor therapy in plaque psoriasis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Xia Z, Liu L, Wang T, et al. Time-course blood transcriptome dynamics of TNF-α inhibitor therapy in a Chinese cohort with psoriasis. J Invest Dermatol. 2026. PMID: 42716213. doi:10.1016/j.jid.2026.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。